BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32541517)

  • 1. Gene expression and prognosis of sirtuin family members in ovarian cancer.
    Zeng Z; Huang Y; Li Y; Huang S; Wang J; Tang Y; Jiang Y
    Medicine (Baltimore); 2020 Jun; 99(24):e20685. PubMed ID: 32541517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.
    Sun X; Wang S; Li Q
    Front Genet; 2019; 10():879. PubMed ID: 31572453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of sirtuins with clinicopathological variables and prognosis in human ovarian cancer.
    He Q; Chen K; Ye R; Dai N; Guo P; Wang L
    Oncol Lett; 2020 Apr; 19(4):3278-3288. PubMed ID: 32256823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm.
    Goes JVC; Viana MA; Sampaio LR; Cavalcante CBA; Melo MML; de Oliveira RTG; Borges DP; Gonçalves PG; Pinheiro RF; Ribeiro-Junior HL
    Gene; 2024 Jul; 915():148428. PubMed ID: 38575099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatic Analysis of the Effect of the
    Yao L; Wang Y
    Biomed Res Int; 2022; 2022():5794118. PubMed ID: 35136826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of sirtuin family members and experimental verification identify SIRT5 as diagnostic biomarkers in clear cell renal cell carcinoma.
    Peng LS; Duan SL; Li RQ; Bai ZY; Ou CL; Wang JP
    PeerJ; 2023; 11():e15154. PubMed ID: 37096064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Values of the Insulin-Like Growth Factor Binding Protein Family in Ovarian Cancer.
    Zheng R; Chen W; Xia W; Zheng J; Zhou Q
    Biomed Res Int; 2020; 2020():7658782. PubMed ID: 33282953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of DNA-binding family regulates the prognosis of ovarian cancer.
    Zhou Q; Mei YD; Yang HJ; Tao YL
    Future Oncol; 2021 May; 17(15):1889-1906. PubMed ID: 33728938
    [No Abstract]   [Full Text] [Related]  

  • 9. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
    Tian X; Han Y; Yu L; Luo B; Hu Z; Li X; Yang Z; Wang X; Huang W; Wang H; Zhang Q; Ma D
    Cancer Biol Ther; 2017 Apr; 18(4):245-251. PubMed ID: 28346042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of the lysyl oxidase family in ovarian cancer.
    Ye M; Zhou J; Gao Y; Pan S; Zhu X
    J Clin Lab Anal; 2020 Dec; 34(12):e23538. PubMed ID: 33058284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer.
    Diao B; Yang P
    Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress on Sirtuins (SIRTs) family modulators.
    Chen M; Tan J; Jin Z; Jiang T; Wu J; Yu X
    Biomed Pharmacother; 2024 May; 174():116481. PubMed ID: 38522239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuins as Important Factors in Pathological States and the Role of Their Molecular Activity Modulators.
    Kratz EM; Sołkiewicz K; Kubis-Kubiak A; Piwowar A
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer.
    Li J; Yue H; Yu H; Lu X; Xue X
    J Ovarian Res; 2019 May; 12(1):47. PubMed ID: 31113446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic roles of Notch receptor mRNA expression in human ovarian cancer.
    Chen C; Wang X; Huang S; Wang L; Han L; Yu S
    Oncotarget; 2017 May; 8(20):32731-32740. PubMed ID: 28415574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes.
    Chen B; Gao C; Wang H; Sun J; Han Z
    Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
    Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
    J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.